NOVEL PHARMA

PRESS RELEASE

Date	Title
2023.09.01	Novel Pharma to Present Abstracts from the Study of GC1130A (MPSIIIA) at the SSIEM Annual Symposium 2023
2023.08.31	Novel Pharma Attends US Sanfilippo Community Conference: Introducing Innovative New Drug Pipeline
2023.04.18	Novel Pharma Recruits Professor Chae Jong-hee of Seoul National University to Speed Rare Disease Treatment Development
2023.01.30	Novel Pharma Receives U.S. FDA Orphan Drug Designation for Treatment of MPSIIIA
2023.01.18	Novel Pharma Receives U.S. FDA Rare Pediatric Disease Designation for Treatment of MPSIIIA
2022.10.27	A Global Rare Disease Authority Julie Eisengart Joins Novel Pharma's Scientific Advisory Board
2022.10.25	Novel Pharma holds a 'MPS summit' with ARMRD
2022.08.22	Renowned Rare Disease Leaders Join Novel Pharma's Scientific Advisory Board
2022.08.08	Novel Pharma Cooperates with Ajou University Hospital in Research and Development of a Treatment for Sanfilippo Syndrome type A
2022.07.29	Novel Pharma, Paving the Way for the Development of Rare Disease Therapeutics